[Follow-up of endometrial cancer].
| Autor: | Gauthier T; CHU de Limoges, HME, Service de gynécologie-obstétrique, avenue Larrey, 87000 Limoges, France., Siegerth F; CHU de Limoges, HME, Service de gynécologie-obstétrique, avenue Larrey, 87000 Limoges, France., Monteil J; CHU de Limoges, Service de médecine nucléaire, avenue Martin-Luther-King, 87000 Limoges, France., Jammet I; CHU de Limoges, Service d'imagerie médicale, 87000 Limoges, France., Saidi N; CHU de Limoges, Service de radiothérapie, 87000 Limoges, France., Tubiana-Mathieu N; CHUde Limoges, Service d'oncologie médicale, 87000 Limoges, France., Aubard Y; CHU de Limoges, HME, Service de gynécologie-obstétrique, avenue Larrey, 87000 Limoges, France. |
|---|---|
| Jazyk: | francouzština |
| Zdroj: | Bulletin du cancer [Bull Cancer] 2014 Jul-Aug; Vol. 101 (7-8), pp. 741-7. |
| DOI: | 10.1684/bdc.2014.1947 |
| Abstrakt: | Available data on appropriate follow-up in endometrial cancer highlight the need of well-conducted studies. Most recurrences tend to occur within three years and involve symptoms. Routine tests are not advocated without symptoms. In case of suspicious recurrence, TEP/CT seems to be the most sensitive and specific method. There is limited evidence to decide whether follow-up schedules with multiple visits result in survival benefits. An appropriate follow-up should be discussed based upon the risk of recurrence. Counselling on the potential symptoms of recurrence should be a major aim. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|